- t2cure’s cell therapy is available through cooperating clinical centres
- t2cure cooperates with experienced partners in research and in the industry.
- t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
- t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.
Contact
t2cure GmbH
Dr. Petra Rück
CEO
Bettinastraße 35-37
60325 Frankfurt am Main
Germany
Phone: +49-69-7561 4687 0
Fax: +49-69-7561 4687 9
E-mail: info
t2cure.com
Prof. Dr. Andreas M. Zeiher
Co-Founder and Scientific Advisor
Dept. of Internal Medicine III / Cardiology
J.W. Goethe University
Theodor-Stern-Kai 7
60590 Frankfurt am Main
Germany
Phone: +49-69-63 01 57 89
Fax: +49-69-63 01 63 74
E-mail: zeiherem.uni-frankfurt.de